If either tamoxifen or estradiol can stimulate the growth of Marco’s tamoxifen-resistance model, are the growth stimulants (estradiol or tamoxifen), that bind to the breast tumor ER, activating the same growth factor pathways? Here, ESR1 is linked to breast neoplasm.